| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.43B | +11.5% |
| Cost of Revenue | $20.91B | +12.9% |
| Gross Profit | $7.52B | +7.8% |
| R&D Expense | $80.0M | +19.4% |
| SG&A Expense | $4.52B | +10.1% |
| Operating Income | $2.21B | +3.1% |
| Pre-tax Income | $1.25B | +0.2% |
| Income Tax | $91.0M | +97.8% |
| Net Income | $1.16B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.94B | +874.4% |
| Accounts Receivable | $3.53B | +9.8% |
| Inventory | $4.77B | +7.0% |
| Current Assets | $10.68B | +29.1% |
| Total Assets | $38.48B | +7.0% |
| Current Liabilities | $2.49B | +2.0% |
| Long-term Debt | $12.48B | -24.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.74B | -1.4% |
| Capital Expenditures | $447.0M | +26.3% |
| Investing Cash Flow | -$474.0M | +68.3% |
| Financing Cash Flow | $399.0M | +124.7% |
| Free Cash Flow | $1.30B | -8.3% |
| -0.3% |
| EPS (Basic) | -$0.01 | — |
| EPS (Diluted) | -$0.01 | — |
| Total Liabilities |
| $19.20B |
| -1.3% |
| Stockholders' Equity | $10.74B | -33.5% |